Table 1.
Demographics and Substance Use Variables
| Mean | SD | IQR | |
|---|---|---|---|
| Age | 34 | 8 | 29 to 37 |
| Female | 63.90% | ||
| White | 89.20% | ||
| College | 51.80% | ||
| Income (USD) | 43000 | 28000 | 20k to 70k |
| Substance Use | |||
| Past Month Opioid Use Days | 7.6 | 9.5 | 0 to 12 |
| Risky Route of Administration | 26.50% | ||
| Past Month Cannabis Use Days | 15 | 12.6 | 1 to 30 |
| Grams Cannabis/Week | 7.5 | 9.5 | 2 to 10 |
| Treatment History | |||
| Current Treatment-Seeking | 8.40% | ||
| Treatment Plans in Next Year | 19.30% | ||
| DSM-5 SUD | |||
| OUD | 67.50% | ||
| OUD Criteria Endorsed | 4.9 | 4 | 1 to 8 |
| CUD | 41.00% | ||
| CUD Criteria Endorsed | 1.7 | 2.1 | 0 to 2 |
| AUD | 59.00% | ||
| AUD Criteria Endorsed | 4 | 3.9 | 0 to 7 |
| Pain | |||
| Average Pain (0–10) | 4.6 | 2.4 | 3 to 6 |
| Pain Effect on Daily Life (0–10) | 4.1 | 2.8 | 1.6 to 6.3 |
| Opioid Relief of Pain (0–100) | 55.1 | 29.6 | 30 to 79 |
| Opioid Demand | |||
| Intensity (Q0) | 1.14 | 0.55 | 0.70 to 1.49 |
| Elasticity (α) | −2.33 | 0.58 | −2.72 to −1.95 |
| Pmax | 0.62 | 0.51 | 0.40 to 0.95 |
| Omax | 1.39 | 0.53 | 1.02 to 1.78 |
| Breakpoint | 0.9 | 0.45 | 0.70 to 1.32 |
| No Breakpoint Reached | 33.70% | ||
| Cannabis Demanda | |||
| Intensity (Q0) | 1.57 | 0.57 | 1.16 to 2.05 |
| Elasticity (α) | −2.14 | 0.52 | −2.47 to −1.79 |
| Pmax | 0.19 | 0.56 | −0.30 to 0.50 |
| Omax | 1.21 | 0.51 | 0.89 to 1.60 |
| Breakpoint | 0.6 | 0.55 | 0.18 to 1.18 |
| No Breakpoint Reached | 23.00% | ||
| Delay Discounting Rates (k)a | |||
| Money | −2.08 | 0.69 | −2.48 to −1.63 |
| Opioid | −1.65 | 0.79 | −2.17 to −1.08 |
| Cannabis | −1.69 | 0.98 | −2.43 to −1.23 |
Note. SUD= substance use disorder; OUD = opioid use disorder; CUD = cannabis use disorder; AUD = alcohol use disorder; Risky Route of Administration = preferred use of intranasal, smoked, or injection administration.
a
Discounting and demand variables were log-transformed prior to analysis and are presented in log values